Last $88.86 USD
Change Today -0.3299 / -0.37%
Volume 13.8M
GILD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 8:10 PM 07/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John F. Milligan Ph.D.

President and Chief Operating Officer, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 4 different industries.

See Board Relationships
53$6,566,287
As of Fiscal Year 2013

Background*

Dr. John F. Milligan, Ph.D. is the President of Pharmasset, Inc. since January 17, 2012. Dr. Milligan is the Chief Operating Officer at Gilead Sciences Inc. since March 9, 2007 and President since May 2008. Dr. Milligan served as Chief Financial Officer of Gilead Sciences Inc., from January 21, 2008 to May 2008 and since March 2002 and its Executive Vice President since July 2003, Principal Accounting Officer until May 2008 and Senior Vice President from March 2002 to ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

2012-Present
President and Director
2013-Present
Director and Member of Audit Committee

Education*

Post-Doctoral Training
University of California-San Francisco
PhD
University of Illinois-Urbana-Champaign
BA
Ohio Wesleyan University

Other Affiliations*

Annual Compensation*

Salary$1,010,010
Total Annual Compensation$1,010,010

Stock Options*

Restricted Stock Awards$2,026,247
All Other Compensation$7,500
Exercised Options1,212,492
Exercised Options Value$74,919,990
Exercisable Options3,459,852
Exercisable Options Value$202,046,227
Unexercisable Options523,776
Unexercisable Options Value$24,847,800
Total Value of Options$301,814,016
Total Number of Options5,196,120

Total Compensation*

Total Annual Cash Compensation$2,540,010
Total Short Term Compensation$1,010,010
Other Long Term Compensation$2,033,747
Total Calculated Compensation$6,566,287
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $88.86 USD -0.3299

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.